Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Sep-Oct;5(5):672-80.
doi: 10.3201/eid0505.990508.

Influence of host genetics on the severity of coccidioidomycosis

Affiliations
Review

Influence of host genetics on the severity of coccidioidomycosis

L Louie et al. Emerg Infect Dis. 1999 Sep-Oct.

Abstract

Coccidioidomycosis, a mild flulike illness in approximately 40% of infected persons, progresses to severe pulmonary or disseminated disease in 1% to 10% of symptomatic cases. We examined host genetic influences on disease severity among class II HLA loci and the ABO blood group. Participants included African-American, Caucasian, and Hispanic persons with mild or severe disseminated coccidioidomycosis from Kern County, California. Among Hispanics, predisposition to symptomatic disease and severe disseminated disease is associated with blood types A and B, respectively. The HLA class II DRB1*1301 allele marks a pre-disposition to severe disseminated disease in each of the three groups. Reduced risk for severe disease is associated with DRB1*0301-DQB1*0201 among Caucasians and Hispanics and with DRB1*1501-DQB1*0602 among African-Americans. These data support the hypothesis that host genes, in particular HLA class II and the ABO blood group, influence susceptibility to severe coccidioidomycosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell Immunol. 1975 Feb;15(2):360-71 - PubMed
    1. Infect Immun. 1998 Aug;66(8):3519-22 - PubMed
    1. Sabouraudia. 1979 Sep;17(3):261-4 - PubMed
    1. Curr Top Med Mycol. 1988;2:199-238 - PubMed
    1. Adv Immunol. 1989;46:111-47 - PubMed

Substances